A randomised, double-blind, placebo-controlled, parallel group, repeat dose study to assess the effect of SB-480848 [darapladib] on overall asthma control in adult subjects with persistent asthma controlled on stable, low-dose, inhaled corticosteroids.

Trial Profile

A randomised, double-blind, placebo-controlled, parallel group, repeat dose study to assess the effect of SB-480848 [darapladib] on overall asthma control in adult subjects with persistent asthma controlled on stable, low-dose, inhaled corticosteroids.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Darapladib (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Jan 2007 New trial centres added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top